Home  |  Contact

ProtParam

User-provided sequence:

        10         20         30         40         50         60 
MPLAFTNPGT PLKRTAAYDN VQWNQNRILT FGTRYTVLII VNNYESYQNI QFGESIGAVA

70 80 90 100 110 120
LDQRTGFLAI AHGQVLDIYK PADSLKWTHH YNYITQLSED ITQLSWGYNF DLLLCASSYT

130 140 150 160 170 180
KLINFSEDKP RLVWSQNRIS DSFLSSTISS DACFIASIET KNPLAKVWQR TSPQGTVSSC

190 200 210 220 230 240
DDFSYLVHPC RVRFSQWSKH LHPDASGSTP FLSTVGYDNV LRIWQVGSRF GSQLMHLSCF

250 260 270 280 290 300
LNLRKYYKSD QPPYCCFIDK DDFTIALAHA ISRHSGQVHK DRILNRLLAL ASGQPHIFLL

310 320 330 340 350 360
FTFECLYIFS LVIDQETLSS FELINQVPTN FPKGALQPDG FIPIYRTSKH EFYDYNIILF

370 380 390 400 410 420
FQNSAREYMF SLTDFFYSDF ELRVSYDFYG HDYPIKSLTR TSNGHGIVSR DVNRICMFQS

430 440 450 460 470 480
YISQDGKNQL ICRFRLLLGE SDFILPLYAG EYAAVLNLNS LKLWHCNEAI PPTLLCTCRQ

490 500 510 520 530 540
VPTSPIITFF ILPVQNNDNS ALCALTEGGH AWFWSVSNEA HDGSAVLRFI DRVNFTKNLN

550 560 570 580 590 600
IASAVDVMGW SSTLNLSSLS SFDQEVFQSI SKDGLLQTWM ARVLGDDKAE ISEISKVQTS

610 620 630 640 650 660
IKSATMIKGS TSKKVAVVSE NNRRLSIFDT RSSEFSEKEE FSSVFDDYGP INDLDWTSTP

670 680 690 700 710 720
NSHSILAVGF LHDVILLCQN RRSYMNDIPC WSRIRRYNLL EYTNSLISDS SWLDNGTLVT

730 740 750 760 770 780
AIGNGLFYFD NSLPEDQSLL FPASLKRSAK NIFDLAYQLN GILPVFHPQL LQQLLLRNQP

790 800 810 820 830 840
FLFTNILLRF YLCLKDDVDM HFLLNMDCSE FYCCDEEISK DLLIKSLSQN SAEILNPAEL

850 860 870 880 890 900
DFEETSVSKH LGLYIDEMIK KLTALLKVKK VKTLTRSSQF LLLNLIEAFN KARALRDSLD

910 920 930 940 950 960
LNGKRYCIML NQYVLSKHQR QLTSLPTREM AWAFHSSNKA VLLDHTKKLH GKPLLWNAVE

970 980 990 1000 1010 1020
EYAIPFWLNE QLLKDVFLEL SRNHYAEIDD RNPENVSLYH IALHKINVFR DLWRLASWHK

1030 1040 1050 1060 1070 1080
ESARTVKLLS NDFSKKKWKV VASKNAFALL SKHRYFYASA FFLLADSCYD AAKVCIRNLK

1090 1100 1110 1120 1130 1140
SISLAIAMTR VYEGDDGPTL KRLINEYVLP LAVSQNDRWL TNWSFTILKQ EKKALQSLVS

1150 1160 1170 1180 1190 1200
PIRSLVSDND FIQLYTSDKN DQEIHENKDS QRNSTNEPVR NKFPSDDPAF ILLYECLRSS

1210 1220 1230 1240 1250 1260
NVQIDESLEY RFVLHNANVY CQLGCDLIAL GLLRNWKFQK NPATAHLETE DYMVTDKQSA

1270 1280 1290
VEKTHDSPKL GKTLMGQDIR PTPDDVPEFN ESAFSFE


References and documentation are available.

Number of amino acids: 1297 Molecular weight: 148739.36 Theoretical pI: 6.37
Amino acid composition: 
Ala (A) 74 5.7% Arg (R) 61 4.7% Asn (N) 80 6.2% Asp (D) 84 6.5% Cys (C) 26 2.0% Gln (Q) 54 4.2% Glu (E) 58 4.5% Gly (G) 44 3.4% His (H) 35 2.7% Ile (I) 78 6.0% Leu (L) 162 12.5% Lys (K) 70 5.4% Met (M) 16 1.2% Phe (F) 76 5.9% Pro (P) 48 3.7% Ser (S) 130 10.0% Thr (T) 63 4.9% Trp (W) 24 1.9% Tyr (Y) 50 3.9% Val (V) 64 4.9% Pyl (O) 0 0.0% Sec (U) 0 0.0% (B) 0 0.0% (Z) 0 0.0% (X) 0 0.0%
Total number of negatively charged residues (Asp + Glu): 142 Total number of positively charged residues (Arg + Lys): 131 Atomic composition: Carbon C 6720 Hydrogen H 10350 Nitrogen N 1778 Oxygen O 1959 Sulfur S 42 Formula: C6720H10350N1778O1959S42 Total number of atoms: 20849 Extinction coefficients: Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water. Ext. coefficient 208125 Abs 0.1% (=1 g/l) 1.399, assuming all pairs of Cys residues form cystines Ext. coefficient 206500 Abs 0.1% (=1 g/l) 1.388, assuming all Cys residues are reduced Estimated half-life: The N-terminal of the sequence considered is M (Met). The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). >20 hours (yeast, in vivo). >10 hours (Escherichia coli, in vivo). Instability index: The instability index (II) is computed to be 46.00 This classifies the protein as unstable. Aliphatic index: 92.18 Grand average of hydropathicity (GRAVY): -0.214